Related Experiment Videos
Essential thrombocythemia terminating in pure erythroleukemia
Andreas Kreft1, Jürgen Burg, Thomas Fischer
1Institut für Pathologie, Klinikum Johannes Gutenberg Universität Mainz, Mainz, Germany. kreft@pathologie.klinik.uni-mainz.de
American Journal of Hematology
|September 25, 2004
Summary
Essential thrombocythemia (ET) rarely transforms into acute leukemia. This case highlights ET transforming into pure erythroleukemia, demonstrating the stem cell
Area of Science:
- Hematology
- Oncology
- Stem Cell Biology
Background:
- Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by elevated platelet counts.
- Transformation to acute leukemia is a rare but serious complication of ET.
- Myeloid or megakaryoblastic differentiation is typically observed in ET-transformed leukemia.
Observation:
- A 58-year-old male with a 10-year history of ET treated with hydroxyurea developed acute leukemia.
- The patient presented with thrombocytosis and normal hemoglobin and leukocyte levels.
- The leukemia exhibited pure erythroid differentiation, a rare phenomenon in ET transformation.
Findings:
- The patient received chemotherapy with cytarabine and daunorubicin, achieving incomplete remission.
- The patient succumbed to the disease two months post-diagnosis of acute erythroleukemia.
- This case represents a rare instance of essential thrombocythemia transforming into erythroleukemia.
Implications:
- Transformation of ET into erythroleukemia suggests the pluripotent potential of the neoplastic hematopoietic stem cell.
- This underscores the capacity of the malignant stem cell to differentiate into various leukemic lineages, including erythroid.
- Further research is warranted to understand the mechanisms driving ET transformation into distinct acute leukemia subtypes.